Efficacy Of Royal Philips Electronics N.V.' Stellarex .035" Low-Dose Drug-Coated Balloon Demonstrated In Clinical Trial At Two Years Post author:Sam Post published:September 14, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like Massachusetts' Flexion Terminates R&D Deal With AstraZeneca PLC September 14, 2017 Zynerba Release: Company Announces Proposed Public Offering Of Common Stock January 18, 2017 Genomics Startup Emerges From Stealth Mode By Leading Harvard Geneticist February 8, 2018